×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [office of vaccines research]
Home >
office of vaccines research
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
220 views
Vaccines and Related Biological Products Advisory Committee Meeting November 14, 2012 Vaccine Adjuvants & Mode of Action for GSK’s AS03 Adjuvanted Influenza.
215 views
Clinical Review Process: An FDA Perspective Karen Midthun, M.D. Deputy Director of Medicine Center for Biologics Evaluation and Research FDA April 15,
214 views
CBER Introduction to Regulation Robert A. Yetter Associate Director for Review Management Center for Biologics Evaluation and Research.
223 views
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Michael J. Brennan, Ph.D. for Kathryn M. Carbone, M.D. Associate Director for.
216 views
Report to the VRBPAC on the Site Visit for the Laboratory of DNA Viruses Keith Peden, PhD Chief, Laboratory of DNA Viruses May 8, 2013 1.
219 views
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (Q-Pan H5N1 Vaccine) Manufactured by GlaxoSmithKline Vaccines and Related Biological Products Advisory.
219 views
0 FDA’s Role in Protecting Your Child’s Health Through Safe and Effective Vaccines Norman W. Baylor, PhD Director, Office of Vaccines Research and Review.
224 views